{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:46:09Z","timestamp":1793400369464,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.dld.2022.09.004","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:45:29Z","timestamp":1664585129000},"page":"727-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNF\u03b1 failure: A retrospective multicenter study"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8416-5432","authenticated-orcid":false,"given":"Guillaume","family":"Le Cosquer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Altwegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Rivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bournet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Boivineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Poullenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bozon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Buscail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Laharie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Gilletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2022.09.004_bib0001","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/ecco-jcc\/jjv190","article-title":"Impact of new treatments on hospitalisation, surgery, infection, and mortality in IBD: a focus paper by the epidemiology committee of ECCO","volume":"10","author":"Annese","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2022.09.004_bib0002","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/gut.2008.155812","article-title":"Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort","volume":"58","author":"Schnitzler","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.09.004_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2011.04679.x","article-title":"Review article: causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-\u03b1 therapy","volume":"34","author":"Danese","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.09.004_bib0004","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2022.09.004_bib0005","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","article-title":"Ustekinumab induction and maintenance therapy in refractory Crohn's disease","volume":"367","author":"Sandborn","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2022.09.004_bib0006","article-title":"Rates of intestinal resection and colectomy in inflammatory bowel disease patients after initiation of biologics: a cohort study","author":"Khoudari","year":"2020","journal-title":"Clinical Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.09.004_bib0007","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1053\/j.gastro.2008.07.069","article-title":"Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study","volume":"135","author":"Feagan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.09.004_bib0008","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","article-title":"Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies","volume":"145","author":"Frolkis","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.09.004_bib0009","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/bjs.11659","article-title":"Decrease in primary but not in secondary abdominal surgery for Crohn's disease: nationwide cohort study, 1990-2014","volume":"107","author":"Kalman","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2022.09.004_bib0010","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","article-title":"Predictability of the postoperative course of Crohn's disease","volume":"99","author":"Rutgeerts","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.09.004_bib0011","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2036.2012.05002.x","article-title":"Review article: the natural history of postoperative Crohn's disease recurrence","volume":"35","author":"Buisson","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.09.004_bib0012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 2: surgical management and special situations","volume":"11","author":"Gionchetti","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2022.09.004_bib0013","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.dld.2019.05.027","article-title":"Anti-TNF\u03b1 agents are the best choice in preventing postoperative Crohn's disease: a meta-analysis","volume":"51","author":"Er\u0151s","year":"2019","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2022.09.004_bib0014","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/j.gastro.2016.02.072","article-title":"Infliximab reduces endoscopic, but not clinical, recurrence of Crohn's disease after ileocolonic resection","volume":"150","author":"Regueiro","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.09.004_bib0015","first-page":"281","article-title":"Previous exposure to multiple anti-TNF is associated with decreased efficiency in preventing postoperative Crohn's disease recurrence","volume":"11","author":"Collins","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2022.09.004_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management","volume":"11","author":"Gomoll\u00f3n","year":"2017","journal-title":"ECCOJC"},{"key":"10.1016\/j.dld.2022.09.004_bib0017","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.dld.2022.09.004_bib0018","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.cgh.2019.03.037","article-title":"Appropriate therapeutic drug monitoring of biologic agents for patients with inflammatory bowel diseases","volume":"17","author":"Papamichael","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.09.004_bib0019","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s00330-008-1034-6","article-title":"Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy","volume":"18","author":"Sailer","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1016\/j.dld.2022.09.004_bib0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3748\/wjg.v24.i5.641","article-title":"Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence","volume":"24","author":"Baillet","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2022.09.004_bib0021","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/apt.13353","article-title":"Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis","volume":"42","author":"De Cruz","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.09.004_bib0022","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(14)61908-5","article-title":"Crohn's disease management after intestinal resection: a randomised trial","volume":"385","author":"De Cruz","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2022.09.004_bib0023","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cgh.2020.03.064","article-title":"Rates of Postoperative Recurrence of Crohn's Disease and Effects of Immunosuppressive and Biologic Therapies","volume":"19","author":"Rivi\u00e8re","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.09.004_bib0024","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.14309\/ajg.0000000000000638","article-title":"Postoperative endoscopic recurrence on the neoterminal ileum but not on the anastomosis is mainly driving long-term outcomes in Crohn's disease","volume":"115","author":"Hammoudi","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.09.004_bib0025","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/ajg.2013.287","article-title":"Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial","volume":"108","author":"Savarino","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2022.09.004_bib0026","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/MIB.0000000000001050","article-title":"Anti-TNF\u03b1 treatment after surgical resection for Crohn\u02bcs disease is effective despite previous pharmacodynamic failure","volume":"23","author":"Assa","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.dld.2022.09.004_bib0027","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/apt.14944","article-title":"Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study","volume":"48","author":"Auzolle","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.09.004_bib0028","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.dld.2011.12.018","article-title":"Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence","volume":"44","author":"Buisson","year":"2012","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2022.09.004_bib0029","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0016-5085(94)90697-1","article-title":"Smoking habits and recurrence in Crohn's disease","volume":"106","author":"Cottone","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2022.09.004_bib0030","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1046\/j.1365-2168.2000.01589.x","article-title":"Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease","volume":"87","author":"Bernell","year":"2000","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2022.09.004_bib0031","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/ibd\/izz290","article-title":"The predictive value of inflammation at ileocecal resection margins for postoperative Crohn's recurrence: a cohort study","volume":"26","author":"Wasmann","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.dld.2022.09.004_bib0032","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/ecco-jcc\/jjy004","article-title":"Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: a systematic review and meta-analysis","volume":"12","author":"Singh","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2022.09.004_bib0033","article-title":"A magnetic resonance imaging index to predict Crohn's disease postoperative recurrence: the MONITOR index","author":"Schaefer","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.09.004_bib0034","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/apt.16315","article-title":"Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti-TNF-\u03b1: results from the ENEIDA registry","volume":"53","author":"Mesonero","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2022.09.004_bib0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ibd\/izx054","article-title":"The use of vedolizumab in preventing postoperative recurrence of Crohn's disease","volume":"24","author":"Yamada","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2022.09.004_bib0036","article-title":"P462 Efficacy of ustekinumab for the prevention of postoperative recurrence in Crohn's disease. Data from clinical practice from the eneida registry","volume":"14","author":"Ma\u00f1osa Ciria","year":"2020","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.dld.2022.09.004_bib0037","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ueg2.12068","article-title":"Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease. United","volume":"9","author":"Buisson","year":"2021","journal-title":"European Gastroenterol J"},{"key":"10.1016\/j.dld.2022.09.004_bib0038","unstructured":"Ma\u00f1osa M., Fern\u00e1ndez-Clotet A., Nos P., et\u00a0al. Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: results from the ENEIDA registry. Digestive and Liver Disease [Internet]. 2022 [cited 2022 Aug 24];0. Available from: https:\/\/www.dldjournalonline.com\/article\/S1590-8658(22)00618-1\/fulltext."},{"key":"10.1016\/j.dld.2022.09.004_bib0039","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2468-1253(16)30078-4","article-title":"Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Mowat","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2022.09.004_bib0040","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00384-016-2632-4","article-title":"Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn's disease following ileocolonic resection","volume":"31","author":"Li","year":"2016","journal-title":"Int J Colorectal Dis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582200696X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582200696X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:21:43Z","timestamp":1761625303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086582200696X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S159086582200696X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2022.09.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of post-operative recurrence of Crohn's disease among patients with prior anti-TNF\u03b1 failure: A retrospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2022.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}